Enhanced susceptibility to MPTP neurotoxicity in magnesium-deficient C57BL/6N mice

Bardgett, 2005, Magnesium deficiency impairs fear conditioning in mice, Brain Res., 1038, 100, 10.1016/j.brainres.2005.01.020 Crawley, 1980, Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines, Pharmacol. Biochem. Behav., 13, 167, 10.1016/0091-3057(80)90067-2 Dauer, 2003, Parkinson's disease: mechanisms and models, Neuron, 39, 889, 10.1016/S0896-6273(03)00568-3 Decollogne, 1997, NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801, Pharmacol. Biochem. Behav., 58, 261, 10.1016/S0091-3057(96)00555-2 Fukae, 2007, Mitochondrial dysfunction in Parkinson's disease, Mitochondrion, 7, 58, 10.1016/j.mito.2006.12.002 Hashimoto, 2008, Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons, Brain Res., 1197, 143, 10.1016/j.brainres.2007.12.033 Hashizume, 1990, An analysis of hypermagnesemia and hypomagnesemia, Jpn. J. Med., 29, 368, 10.2169/internalmedicine1962.29.368 Koenig, 1996, Synaptic vesicles have two distinct recycling pathways, J. Cell Biol., 135, 797, 10.1083/jcb.135.3.797 Mori, 2005, Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice, Neurosci. Res., 51, 265, 10.1016/j.neures.2004.11.008 Mori, 1992, Identification by mutagenesis of a Mg(2+)-block site of the NMDA receptor channel, Nature, 358, 673, 10.1038/358673a0 Murck, 2002, Magnesium and affective disorders, Nutr. Neurosci., 5, 375, 10.1080/1028415021000039194 Olanow, 1999, Etiology and pathogenesis of Parkinson's disease, Annu. Rev. Neurosci., 22, 123, 10.1146/annurev.neuro.22.1.123 Oyanagi, 2006, Magnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam, Neuropathology, 26, 115, 10.1111/j.1440-1789.2006.00672.x Porsolt, 1977, Behavioral despair in mice: a primary screening test for antidepressants, Arch. Int. Pharmacodyn. Ther., 229, 327 Rasmussen, 1989, Depression and magnesium deficiency, Int. J. Psychiatry Med., 19, 57, 10.2190/NKCD-1RB1-QMA9-G1VN Schuurman, 2002, Increased risk of Parkinson's disease after depression: a retrospective cohort study, Neurology, 58, 1501, 10.1212/WNL.58.10.1501 Seelig, 1994, Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review), J. Am. Coll. Nutr., 13, 429, 10.1080/07315724.1994.10718432 Singewald, 2004, Magnesium-deficient diet alters depression- and anxiety-related behavior in mice—influence of desipramine and Hypericum perforatum extract, Neuropharmacology, 47, 1189, 10.1016/j.neuropharm.2004.08.010 Smith, 2002, Stress-induced Parkinson's disease: a working hypothesis, Physiol. Behav., 77, 527, 10.1016/S0031-9384(02)00939-3 Snyder, 1985, Stress-induced neurological impairments in an animal model of parkinsonism, Ann. Neurol., 18, 544, 10.1002/ana.410180506 Sobolevskii, 2002, Blocker studies of the functional architecture of the NMDA receptor channel, Neurosci. Behav. Physiol., 32, 157, 10.1023/A:1013927409034 Topf, 2003, Hypomagnesemia and hypermagnesemia, Rev. Endocr. Metab. Disord., 4, 195, 10.1023/A:1022950321817 Urakami, 1988, Increase of striatal dopamine turnover by stress in MPTP-treated mice, Clin. Neuropharmacol., 11, 360, 10.1097/00002826-198808000-00004 Zigmond, 1984, Parkinson's disease: studies with an animal model, Life Sci., 35, 5, 10.1016/0024-3205(84)90147-4